Q-linea AB Stock

QLINEA

SE0025420714

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 12:00:00 2026-09-23 EDT			5-day change	1st Jan Change
18.00 ^SEK	-1.37%		-0.28%	-27.83%

08-20	Sweden's Q-linea Names New Finance Chief	MT
08-20	Q-linea appoints Malin Svensson as new CFO	FW

Last Transcript: Q-linea AB

Q-linea AB, Q2 2026 Earnings Call, Jul 10, 2026

07-10

More transcripts

Analysts' recommendations: Q-linea AB

25-09-19	Redeye Lowers Fair Value for Q-linea to 55 SEK (Previously 60 SEK)	FW
25-03-03	Redeye lowers motivated value for Q-linea to SEK 0.13 (0.20)	FW
25-01-10	Substantial dilution to be expected in Q-linea, Redeye lowers motivated value	FW
25-01-02	Precise and Isofol 2024 winners on Nasdaq Stockholm, Xbrane and Fingerprint losers of the year	FW
24-03-04	Redeye lowers motivated value for Q-linea - revises sales forecast downwards	FW

More recommendations

Managers and Directors: Q-linea AB

Manager	Title	Age	Since
Stuart Gander CEO	Chief Executive Officer	48	2025-10-18
Annika Blondeau Henriksson DFI	Director of Finance/CFO	57	2026-06-14
Anders Lundin DFI	Director of Finance/CFO	62	2017-12-31

Director	Title	Age	Since
Jonas Jarvius BRD	Director/Board Member	55	2024-02-29
Erika Kjellberg-Eriksson CHM	Chairman	64	2017-12-31
Mario Gualano BRD	Director/Board Member	57	2020-05-25

More insiders

Medical Diagnostic & Testing Equipment

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
Q-LINEA AB	-1.37%	-0.28%	-39.78%	-99.44%	35.08M
SARTORIUS AG	0.00%	+6.04%	+20.65%	-20.42%	18.09B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+1.81%	+3.51%	-38.15%	+30.15%	1.92B
ECKERT & ZIEGLER SE	-0.96%	+0.82%	-31.98%	+24.76%	894M
VAREX IMAGING CORPORATION	-0.16%	-0.11%	+51.85%	-2.74%	779M
QUIDELORTHO CORPORATION	-5.48%	-3.99%	-62.32%	-85.55%	750M
CONTEC MEDICAL SYSTEMS CO.,LTD	+0.70%	+9.49%	-30.73%	-46.23%	687M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-0.03%	+2.23%	-39.33%	-52.09%	581M
908 DEVICES INC.	-2.15%	+10.28%	+44.90%	+80.83%	462M
REVENIO GROUP OYJ	+1.67%	-13.43%	-53.46%	-47.61%	359M
Average	-0.65%	+4.26%	-17.83%	-21.83%	2.46B
Weighted average by Cap.	-0.13%	+5.52%	+9.02%	-16.32%

See all sector performances

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

10-29 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-09-23	SEK 18.00	-1.37%	4,605
26-09-22	SEK 18.25	+1.11%	27,922
26-09-21	SEK 18.05	-0.82%	878
26-09-18	SEK 18.20	+2.25%	7,964
26-09-17	SEK 17.80	-0.56%	2,517

Delayed Quote Nasdaq Stockholm

More quotes

Quarterly revenue - Rate of surprise

Company calendar

Market Cap	341M 34.42M 30.21M 28.4M 25.96M 48.51M 3.3B 48.87M 132M 1.68B 129M 126M 5.45B	P/E 2024	-0.37x	P/E 2025	-0.91x
Enterprise Value	88.82M 8.96M 7.87M 7.39M 6.76M 12.63M 859M 12.73M 34.43M 438M 33.66M 32.92M 1.42B	EV / Sales 2024	49.8x	EV / Sales 2025	14.4x
Free-Float	87.08%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Nasdaq Stockholm	QLINEA	Delayed
Deutsche Boerse AG	3F80	Delayed
CBOE		Real-time
CBOE		Real-time
Boerse Muenchen	3F80	Real-time
CBOE	QLINEs	Real-time

08-20	Sweden's Q-linea Names New Finance Chief	MT
08-20	Q-linea appoints Malin Svensson as new CFO	FW
08-20	Q-linea Appoints New CFO	FW
08-20	Q-linea AB Announces Appointment of Malin Svensson to Chief Financial Officer, Effective No Later Than January 1, 2027	CI
08-19	Q-linea AB Announces Appointment of Malin Svensson as Head of Investor Relations, Effective January 1, 2027	CI
08-18	Stockholm stocks fell again on Tuesday, the OMXS30 index slipped 0.7 percent	FW
08-18	Stocks extend losses in Stockholm, OMXS30 index down 0.5 percent	FW
08-18	Q-linea Wins Contract for ASTar System in US	MT
08-18	Q-linea signs master agreement with US purchasing organization Premier	FW
08-18	Q-linea signs a framework agreement with Premier	FW
08-18	Q-linea AB Announces Contract Position With Premier, Inc	CI
08-10	The Stockholm stock exchange opened the week slightly lower, the OMXS30 index fell 0.2 percent	FW
08-10	Mixed trade on the Stockholm Stock Exchange, the OMXS30 index slips 0.1%	FW

08-20	Q-linea appoints Malin Svensson as new Chief Financial Officer	AQ
08-18	Q-linea awarded a contract position with Premier, Inc.	AQ
08-10	Q-linea Announces ASTar® Contract With Large Health System in the U.S. Mid-Atlantic Region	AQ
07-10	Q linea : Interim report January 1 - June 30 2026	PU
05-29	Annika Blondeau Henriksson new interim CFO	AQ

1 day	-1.92%
1 week	-0.28%
Current month	-4.26%
1 month	-1.91%
3 months	+2.27%
6 months	-19.16%
Current year	-27.83%

Q-linea AB Stock

Stocks

QLINEA

SE0025420714

Advanced Medical Equipment & Technology

Valuation: Q-linea AB

Chart: Q-linea AB

Latest news: Q-linea AB

Last Transcript: Q-linea AB

Analysts' recommendations: Q-linea AB

Press Releases: Q-linea AB

Quotes and Performance

Price Extremes

Managers and Directors: Q-linea AB

Latest insider transactions

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

1 week	17.4	19.4
1 month	17.4	19.4
Current year	14.55	38.42
1 year	14.55	38.42
3 years	14.55	5,600
5 years	14.55	146,600
10 years	14.55	187,500

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/21/25	Johan Bygge	Buy	Chairman	4,000	0.0207%
11/12/25	Stuart Gander	Exercice	Chief Executive Officer	35,400	0.1833%
11/11/25	Erika Kjellberg-Eriksson	Buy	Director	19,740	0.1022%

	2024	2025
Net sales	4.14M 418K 367K 345K 315K 589K 40.01M 593K 1.6M 20.4M 1.57M 1.53M 66.13M	15.28M 1.54M 1.35M 1.27M 1.16M 2.17M 148M 2.19M 5.93M 75.33M 5.79M 5.67M 244M
Net income	-217M -21.88M -19.21M -18.06M -16.51M -30.85M -2.1B -31.08M -84.07M -1.07B -82.18M -80.38M -3.47B	-182M -18.41M -16.16M -15.19M -13.89M -25.96M -1.76B -26.15M -70.74M -899M -69.15M -67.64M -2.92B
Net Debt	126M 12.67M 11.12M 10.45M 9.56M 17.86M 1.21B 17.99M 48.67M 619M 47.57M 46.53M 2.01B	-252M -25.46M -22.34M -21M -19.2M -35.88M -2.44B -36.15M -97.79M -1.24B -95.59M -93.5M -4.03B